1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Nootropics Market
2.2. Global Nootropics Market, By Application, 2023 (US$ Million)
2.3. Global Nootropics Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Nootropics Market: Competitive Analysis
3.1. Market Positioning of Key Nootropics Market Vendors
3.2. Strategies Adopted by Nootropics Market Vendors
3.3. Key Industry Strategies
4. Nootropics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Nootropics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Nootropics Market: By Application, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Memory Enhancement
5.3.2. Mood and Depression
5.3.3. Attention and Focus
5.3.4. Longevity and Anti-aging
5.3.5. Sleep, Recovery and Dream Enhancement
5.3.6. Anxiety


6. North America Nootropics Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Nootropics Market: By Application, 2022-2032, USD (Million)
6.3.Nootropics Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Nootropics Market: By Application, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Nootropics Market: By Application, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Nootropics Market: By Application, 2022-2032, USD (Million)

7. UK and European Union Nootropics Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Nootropics Market: By Application, 2022-2032, USD (Million)
7.3.Nootropics Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Nootropics Market: By Application, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Nootropics Market: By Application, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Nootropics Market: By Application, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Nootropics Market: By Application, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Nootropics Market: By Application, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Nootropics Market: By Application, 2022-2032, USD (Million)

8. Asia Pacific Nootropics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Nootropics Market: By Application, 2022-2032, USD (Million)
8.3.Nootropics Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Nootropics Market: By Application, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Nootropics Market: By Application, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Nootropics Market: By Application, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Nootropics Market: By Application, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Nootropics Market: By Application, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Nootropics Market: By Application, 2022-2032, USD (Million)

9. Latin America Nootropics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Nootropics Market: By Application, 2022-2032, USD (Million)
9.3.Nootropics Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Nootropics Market: By Application, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Nootropics Market: By Application, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Nootropics Market: By Application, 2022-2032, USD (Million)

10. Middle East and Africa Nootropics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Nootropics Market: By Application, 2022-2032, USD (Million)
10.3.Nootropics Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Nootropics Market: By Application, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Nootropics Market: By Application, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Nootropics Market: By Application, 2022-2032, USD (Million)

11. Company Profile
11.1. Nootrobox, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Cephalon, Inc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Purelife Bioscience Co. Ltd.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Peak Nootropics
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Nootrico
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. SupNootropic Biological Technology Co. Ltd.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. AlternaScript LLC
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Accelerated Intelligence, Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Onnit Labs LLC
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Powder City LLC
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Ceretropic
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives
11.12. Nootropic Source
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Portfolio
11.12.4. Strategic Initiatives
11.13. Clarity Nootropics
11.13.1. Company Overview
11.13.2. Financial Performance
11.13.3. Product Portfolio
11.13.4. Strategic Initiatives